Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China flag China · Delayed Price · Currency is CNY
109.11
-1.84 (-1.66%)
May 19, 2025, 2:45 PM CST
269.24%
Market Cap 9.94B
Revenue (ttm) 488.01M
Net Income (ttm) -208.29M
Shares Out 89.58M
EPS (ttm) -2.21
PE Ratio n/a
Forward PE 184.92
Dividend 0.20 (0.18%)
Ex-Dividend Date n/a
Volume 3,389,963
Average Volume 2,926,337
Open 108.20
Previous Close 110.95
Day's Range 106.39 - 110.50
52-Week Range 22.94 - 142.00
Beta 1.59
RSI 50.15
Earnings Date Apr 30, 2025

About Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, mi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 1,036
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688068
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.